CYCLIC PEPTIDE LHRH ANTAGONISTS

SAUER DARYL R, HAVIV FORTUNA
1995
OA: closed Metadata only
⚙ AI-generated summary by qwen3.7-flash, 2026-08-15 ⓘ

Cyclic peptide LHRH antagonists effectively inhibit LHRH and are useful for treating sex hormone-mediated diseases, including endometriosis, prostate cancer, uterine fibroids, and precocious puberty.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A class of cyclic peptides are effective inhibitors of LHRH and are useful in the treatment of disease conditions which are mediated by sex hormones including prostate cancer, endometriosis, uterine fibroids, and precocious puberty.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-06T06:10:23.601157+00:00